| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arsenic | 26 | 2025 | 272 | 8.090 |
Why?
|
| DNA Methylation | 13 | 2025 | 703 | 4.980 |
Why?
|
| Genome-Wide Association Study | 40 | 2025 | 1763 | 3.520 |
Why?
|
| Telomere | 11 | 2023 | 121 | 3.480 |
Why?
|
| Arsenic Poisoning | 11 | 2023 | 104 | 2.950 |
Why?
|
| Polymorphism, Single Nucleotide | 40 | 2025 | 2494 | 2.940 |
Why?
|
| Genetic Predisposition to Disease | 30 | 2025 | 2473 | 2.580 |
Why?
|
| Aging | 6 | 2025 | 766 | 2.350 |
Why?
|
| Environmental Exposure | 18 | 2023 | 357 | 2.320 |
Why?
|
| Methyltransferases | 7 | 2025 | 213 | 2.230 |
Why?
|
| Quantitative Trait Loci | 11 | 2024 | 632 | 2.230 |
Why?
|
| Bangladesh | 28 | 2025 | 339 | 2.200 |
Why?
|
| Telomere Homeostasis | 6 | 2021 | 30 | 2.200 |
Why?
|
| Mendelian Randomization Analysis | 12 | 2024 | 50 | 2.170 |
Why?
|
| Epigenesis, Genetic | 8 | 2025 | 554 | 1.900 |
Why?
|
| Prostatic Neoplasms | 13 | 2025 | 1795 | 1.840 |
Why?
|
| Gene-Environment Interaction | 7 | 2018 | 120 | 1.780 |
Why?
|
| Arsenicals | 5 | 2023 | 49 | 1.580 |
Why?
|
| Skin Diseases | 8 | 2019 | 176 | 1.460 |
Why?
|
| Genetic Variation | 14 | 2024 | 1423 | 1.430 |
Why?
|
| CpG Islands | 5 | 2025 | 169 | 1.260 |
Why?
|
| Telomere Shortening | 4 | 2020 | 25 | 1.260 |
Why?
|
| Organ Specificity | 6 | 2025 | 285 | 1.210 |
Why?
|
| Drinking Water | 5 | 2023 | 70 | 1.160 |
Why?
|
| Multifactorial Inheritance | 8 | 2025 | 201 | 1.110 |
Why?
|
| Water Pollutants, Chemical | 6 | 2020 | 140 | 1.080 |
Why?
|
| Humans | 101 | 2025 | 95971 | 1.050 |
Why?
|
| Male | 60 | 2025 | 45735 | 1.040 |
Why?
|
| Pancreatic Neoplasms | 6 | 2017 | 725 | 0.960 |
Why?
|
| Oxygenases | 1 | 2025 | 17 | 0.940 |
Why?
|
| Middle Aged | 47 | 2025 | 28255 | 0.930 |
Why?
|
| Glutathione Transferase | 1 | 2025 | 116 | 0.920 |
Why?
|
| Aged | 40 | 2025 | 20877 | 0.910 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 2059 | 0.900 |
Why?
|
| Longitudinal Studies | 11 | 2024 | 1173 | 0.890 |
Why?
|
| C-Reactive Protein | 4 | 2009 | 207 | 0.880 |
Why?
|
| Disease | 5 | 2020 | 92 | 0.880 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2012 | 1231 | 0.860 |
Why?
|
| Data Interpretation, Statistical | 3 | 2015 | 312 | 0.830 |
Why?
|
| Female | 55 | 2025 | 49938 | 0.810 |
Why?
|
| Adult | 40 | 2025 | 28637 | 0.810 |
Why?
|
| Risk Factors | 22 | 2023 | 5949 | 0.810 |
Why?
|
| Cigarette Smoking | 1 | 2024 | 48 | 0.800 |
Why?
|
| Leukocytes | 4 | 2023 | 218 | 0.750 |
Why?
|
| Cacodylic Acid | 3 | 2021 | 22 | 0.740 |
Why?
|
| Odds Ratio | 11 | 2019 | 711 | 0.730 |
Why?
|
| Smoking | 5 | 2024 | 650 | 0.730 |
Why?
|
| Parents | 2 | 2019 | 307 | 0.710 |
Why?
|
| Chemically-Induced Disorders | 1 | 2020 | 2 | 0.650 |
Why?
|
| Information Seeking Behavior | 1 | 2020 | 18 | 0.640 |
Why?
|
| Blood | 1 | 2019 | 69 | 0.620 |
Why?
|
| Research Subjects | 1 | 2020 | 73 | 0.610 |
Why?
|
| Case-Control Studies | 13 | 2018 | 1957 | 0.610 |
Why?
|
| Algorithms | 3 | 2025 | 2011 | 0.610 |
Why?
|
| Ammonia-Lyases | 1 | 2019 | 6 | 0.610 |
Why?
|
| Glutamate Formimidoyltransferase | 1 | 2019 | 6 | 0.610 |
Why?
|
| Serum Amyloid A Protein | 2 | 2009 | 25 | 0.590 |
Why?
|
| Diet | 4 | 2012 | 461 | 0.570 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2023 | 47 | 0.570 |
Why?
|
| Breast Neoplasms | 12 | 2020 | 3142 | 0.530 |
Why?
|
| Chromosomes, Human | 1 | 2017 | 67 | 0.530 |
Why?
|
| DNA Helicases | 1 | 2017 | 90 | 0.530 |
Why?
|
| Causality | 3 | 2019 | 82 | 0.520 |
Why?
|
| Prostate-Specific Antigen | 2 | 2025 | 346 | 0.520 |
Why?
|
| Young Adult | 18 | 2023 | 7001 | 0.510 |
Why?
|
| Mortality | 1 | 2017 | 153 | 0.490 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2016 | 137 | 0.480 |
Why?
|
| Saliva | 1 | 2016 | 128 | 0.480 |
Why?
|
| Body Mass Index | 4 | 2016 | 817 | 0.480 |
Why?
|
| Prospective Studies | 13 | 2022 | 4663 | 0.460 |
Why?
|
| Phenotype | 9 | 2024 | 2580 | 0.460 |
Why?
|
| Blotting, Southern | 1 | 2014 | 128 | 0.450 |
Why?
|
| Models, Genetic | 4 | 2024 | 983 | 0.450 |
Why?
|
| Neoplasms | 5 | 2023 | 3246 | 0.440 |
Why?
|
| Models, Statistical | 2 | 2015 | 594 | 0.440 |
Why?
|
| Genomics | 5 | 2024 | 855 | 0.430 |
Why?
|
| Smoking Cessation | 2 | 2016 | 272 | 0.430 |
Why?
|
| Alleles | 6 | 2020 | 1157 | 0.430 |
Why?
|
| Longevity | 2 | 2019 | 60 | 0.420 |
Why?
|
| Genotype | 7 | 2016 | 1882 | 0.420 |
Why?
|
| Folic Acid | 3 | 2023 | 65 | 0.400 |
Why?
|
| DNA | 3 | 2016 | 1332 | 0.400 |
Why?
|
| Gene Regulatory Networks | 2 | 2017 | 321 | 0.400 |
Why?
|
| Gene Expression | 3 | 2024 | 1321 | 0.380 |
Why?
|
| Cognition Disorders | 1 | 2013 | 244 | 0.360 |
Why?
|
| Genome, Human | 5 | 2019 | 824 | 0.360 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 1875 | 0.360 |
Why?
|
| Cohort Studies | 10 | 2025 | 3093 | 0.350 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2011 | 80 | 0.340 |
Why?
|
| Adolescent | 16 | 2024 | 9888 | 0.340 |
Why?
|
| Life Style | 3 | 2015 | 186 | 0.340 |
Why?
|
| Computer Simulation | 5 | 2018 | 1158 | 0.340 |
Why?
|
| Sex Characteristics | 3 | 2020 | 339 | 0.340 |
Why?
|
| Thinness | 1 | 2009 | 45 | 0.310 |
Why?
|
| Biomarkers | 3 | 2016 | 1933 | 0.310 |
Why?
|
| Patents as Topic | 1 | 2009 | 12 | 0.300 |
Why?
|
| Cognition | 1 | 2013 | 635 | 0.300 |
Why?
|
| Genetic Testing | 2 | 2010 | 564 | 0.290 |
Why?
|
| Aged, 80 and over | 8 | 2018 | 7205 | 0.290 |
Why?
|
| Interleukin-6 | 1 | 2009 | 283 | 0.270 |
Why?
|
| Cross-Cultural Comparison | 1 | 2007 | 35 | 0.270 |
Why?
|
| Gene Frequency | 3 | 2019 | 703 | 0.270 |
Why?
|
| Carcinoma | 1 | 2010 | 449 | 0.250 |
Why?
|
| Vitamin D | 2 | 2019 | 273 | 0.250 |
Why?
|
| Genetic Linkage | 2 | 2007 | 623 | 0.250 |
Why?
|
| Methylation | 2 | 2019 | 295 | 0.240 |
Why?
|
| Body Height | 2 | 2016 | 108 | 0.230 |
Why?
|
| Prognosis | 3 | 2012 | 4024 | 0.230 |
Why?
|
| Multigene Family | 1 | 2025 | 213 | 0.220 |
Why?
|
| Feeding Behavior | 1 | 2007 | 338 | 0.220 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2024 | 188 | 0.210 |
Why?
|
| Genetic Privacy | 1 | 2023 | 12 | 0.210 |
Why?
|
| Biomarkers, Tumor | 2 | 2014 | 1662 | 0.210 |
Why?
|
| Epistasis, Genetic | 2 | 2018 | 92 | 0.210 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 1208 | 0.210 |
Why?
|
| Chromosomes, Human, Y | 1 | 2023 | 26 | 0.200 |
Why?
|
| Alternative Splicing | 1 | 2024 | 220 | 0.200 |
Why?
|
| Conduct Disorder | 1 | 2024 | 65 | 0.200 |
Why?
|
| Bisexuality | 1 | 2003 | 36 | 0.200 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 1534 | 0.200 |
Why?
|
| Water Pollution, Chemical | 2 | 2015 | 21 | 0.200 |
Why?
|
| Genomic Instability | 1 | 2023 | 88 | 0.200 |
Why?
|
| Dietary Supplements | 1 | 2023 | 133 | 0.200 |
Why?
|
| Inflammation | 3 | 2018 | 1069 | 0.190 |
Why?
|
| Mutation, Missense | 2 | 2019 | 302 | 0.190 |
Why?
|
| Suicide, Attempted | 1 | 2003 | 140 | 0.180 |
Why?
|
| Epigenomics | 1 | 2022 | 107 | 0.180 |
Why?
|
| Attitude | 2 | 2020 | 137 | 0.180 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 771 | 0.170 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 2876 | 0.170 |
Why?
|
| Blood Proteins | 1 | 2021 | 151 | 0.170 |
Why?
|
| Pulmonary Fibrosis | 1 | 2023 | 152 | 0.170 |
Why?
|
| Bias | 2 | 2012 | 139 | 0.170 |
Why?
|
| Chromosome Mapping | 2 | 2022 | 1083 | 0.170 |
Why?
|
| Health Status | 2 | 2016 | 386 | 0.170 |
Why?
|
| United Kingdom | 1 | 2021 | 192 | 0.160 |
Why?
|
| Genetic Pleiotropy | 1 | 2020 | 29 | 0.160 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 72 | 0.160 |
Why?
|
| Chicago | 1 | 2025 | 1504 | 0.160 |
Why?
|
| Risk Assessment | 4 | 2017 | 2478 | 0.160 |
Why?
|
| Sex Factors | 4 | 2020 | 1132 | 0.160 |
Why?
|
| Homosexuality, Male | 1 | 2003 | 332 | 0.160 |
Why?
|
| United States | 6 | 2018 | 7762 | 0.160 |
Why?
|
| Multifunctional Enzymes | 1 | 2019 | 7 | 0.150 |
Why?
|
| Tungsten | 1 | 2018 | 6 | 0.150 |
Why?
|
| Cadmium | 1 | 2018 | 30 | 0.150 |
Why?
|
| Transcriptome | 3 | 2024 | 771 | 0.150 |
Why?
|
| Indians, North American | 1 | 2018 | 48 | 0.150 |
Why?
|
| Signal Transduction | 1 | 2019 | 3587 | 0.140 |
Why?
|
| Risk | 3 | 2016 | 669 | 0.140 |
Why?
|
| Haptoglobins | 1 | 2017 | 9 | 0.140 |
Why?
|
| Stromal Cells | 1 | 2018 | 155 | 0.140 |
Why?
|
| Proportional Hazards Models | 3 | 2023 | 900 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 65 | 0.130 |
Why?
|
| Mutation | 1 | 2009 | 4371 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 2040 | 0.130 |
Why?
|
| Waist-Hip Ratio | 1 | 2016 | 21 | 0.130 |
Why?
|
| Water Supply | 3 | 2011 | 66 | 0.130 |
Why?
|
| Sex Distribution | 1 | 2016 | 174 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 1 | 2017 | 155 | 0.120 |
Why?
|
| Software | 1 | 2020 | 699 | 0.120 |
Why?
|
| Adiposity | 1 | 2016 | 80 | 0.120 |
Why?
|
| Biometry | 1 | 2015 | 72 | 0.120 |
Why?
|
| Genotyping Techniques | 1 | 2015 | 71 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 298 | 0.110 |
Why?
|
| Vitamin E | 1 | 2014 | 34 | 0.110 |
Why?
|
| Parity | 1 | 2015 | 97 | 0.110 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2015 | 63 | 0.110 |
Why?
|
| Asia | 1 | 2014 | 105 | 0.110 |
Why?
|
| Selenium | 1 | 2014 | 46 | 0.110 |
Why?
|
| Biological Assay | 1 | 2014 | 84 | 0.110 |
Why?
|
| Polymorphism, Genetic | 2 | 2015 | 828 | 0.110 |
Why?
|
| Chemoprevention | 1 | 2014 | 93 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 930 | 0.110 |
Why?
|
| Databases as Topic | 1 | 2014 | 96 | 0.110 |
Why?
|
| Drinking | 2 | 2011 | 35 | 0.110 |
Why?
|
| Phosphofructokinase-1, Muscle Type | 1 | 2014 | 9 | 0.110 |
Why?
|
| Environmental Pollutants | 1 | 2014 | 56 | 0.110 |
Why?
|
| Colorectal Neoplasms | 3 | 2017 | 1071 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2013 | 80 | 0.100 |
Why?
|
| Food Contamination | 1 | 2013 | 35 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 3901 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2016 | 484 | 0.100 |
Why?
|
| Environment | 1 | 2015 | 231 | 0.100 |
Why?
|
| Information Dissemination | 1 | 2014 | 127 | 0.100 |
Why?
|
| Oryza | 1 | 2013 | 45 | 0.100 |
Why?
|
| Genetic Markers | 2 | 2020 | 479 | 0.100 |
Why?
|
| Sample Size | 1 | 2013 | 128 | 0.100 |
Why?
|
| Proteins | 2 | 2010 | 817 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 750 | 0.100 |
Why?
|
| Keratosis | 1 | 2012 | 21 | 0.100 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 170 | 0.100 |
Why?
|
| C-Peptide | 1 | 2012 | 186 | 0.090 |
Why?
|
| Random Allocation | 1 | 2012 | 332 | 0.090 |
Why?
|
| Food | 1 | 2012 | 93 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2014 | 290 | 0.090 |
Why?
|
| Androgens | 1 | 2012 | 179 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 3635 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 382 | 0.090 |
Why?
|
| Cucurbitaceae | 1 | 2010 | 4 | 0.090 |
Why?
|
| Vegetables | 1 | 2010 | 50 | 0.080 |
Why?
|
| Diabetes Complications | 1 | 2012 | 175 | 0.080 |
Why?
|
| Molecular Epidemiology | 1 | 2010 | 58 | 0.080 |
Why?
|
| Vitamin B Complex | 1 | 2010 | 21 | 0.080 |
Why?
|
| Epidemiologic Studies | 1 | 2010 | 17 | 0.080 |
Why?
|
| Therapeutics | 1 | 2010 | 12 | 0.080 |
Why?
|
| Lung Neoplasms | 3 | 2017 | 2464 | 0.080 |
Why?
|
| Age Factors | 2 | 2019 | 1963 | 0.080 |
Why?
|
| Occupational Exposure | 1 | 2010 | 89 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 625 | 0.080 |
Why?
|
| Precancerous Conditions | 1 | 2010 | 206 | 0.080 |
Why?
|
| Ownership | 1 | 2009 | 28 | 0.070 |
Why?
|
| Long QT Syndrome | 1 | 2009 | 39 | 0.070 |
Why?
|
| Rural Population | 1 | 2009 | 171 | 0.070 |
Why?
|
| Cause of Death | 1 | 2009 | 278 | 0.070 |
Why?
|
| Washington | 1 | 2008 | 52 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 1105 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2010 | 819 | 0.070 |
Why?
|
| Cystic Fibrosis | 1 | 2009 | 121 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 777 | 0.070 |
Why?
|
| Genetic Loci | 1 | 2019 | 260 | 0.070 |
Why?
|
| SEER Program | 1 | 2008 | 234 | 0.070 |
Why?
|
| Factor Analysis, Statistical | 1 | 2007 | 118 | 0.070 |
Why?
|
| Linkage Disequilibrium | 2 | 2020 | 481 | 0.070 |
Why?
|
| Bayes Theorem | 1 | 2019 | 404 | 0.070 |
Why?
|
| Genetic Heterogeneity | 1 | 2007 | 70 | 0.060 |
Why?
|
| Survivors | 1 | 2008 | 204 | 0.060 |
Why?
|
| Surveys and Questionnaires | 3 | 2014 | 2863 | 0.060 |
Why?
|
| Family Health | 1 | 2007 | 159 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 1194 | 0.060 |
Why?
|
| Foot Deformities, Congenital | 1 | 2006 | 11 | 0.060 |
Why?
|
| Talus | 1 | 2006 | 19 | 0.060 |
Why?
|
| Incidence | 3 | 2017 | 1705 | 0.060 |
Why?
|
| Pharmacogenetics | 1 | 2010 | 456 | 0.060 |
Why?
|
| HLA-C Antigens | 1 | 2005 | 18 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2019 | 1536 | 0.060 |
Why?
|
| Prevalence | 2 | 2013 | 1345 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 595 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2016 | 301 | 0.050 |
Why?
|
| Choline | 1 | 2023 | 28 | 0.050 |
Why?
|
| Adolescent Development | 1 | 2024 | 24 | 0.050 |
Why?
|
| Food, Fortified | 1 | 2023 | 18 | 0.050 |
Why?
|
| Arachidonic Acids | 1 | 2023 | 38 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2024 | 297 | 0.050 |
Why?
|
| Gray Matter | 1 | 2024 | 43 | 0.050 |
Why?
|
| Brain | 2 | 2024 | 2480 | 0.050 |
Why?
|
| Adolescent Behavior | 1 | 2024 | 115 | 0.050 |
Why?
|
| Psoriasis | 1 | 2005 | 254 | 0.050 |
Why?
|
| Metabolomics | 1 | 2023 | 98 | 0.050 |
Why?
|
| Metabolome | 1 | 2023 | 63 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1981 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2006 | 563 | 0.050 |
Why?
|
| Child | 2 | 2024 | 7624 | 0.040 |
Why?
|
| Executive Function | 1 | 2022 | 106 | 0.040 |
Why?
|
| Animals | 2 | 2018 | 28924 | 0.040 |
Why?
|
| Pneumonia, Bacterial | 1 | 2001 | 30 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2016 | 599 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 639 | 0.040 |
Why?
|
| Chromosomes, Human, X | 1 | 2020 | 57 | 0.040 |
Why?
|
| Urinary Tract Infections | 1 | 2001 | 84 | 0.040 |
Why?
|
| Ovarian Neoplasms | 2 | 2017 | 828 | 0.040 |
Why?
|
| Communicable Diseases | 1 | 2001 | 69 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1969 | 0.040 |
Why?
|
| Impulsive Behavior | 1 | 2022 | 290 | 0.040 |
Why?
|
| Penetrance | 1 | 2018 | 48 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2006 | 1731 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 163 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 417 | 0.030 |
Why?
|
| Influenza, Human | 1 | 2001 | 370 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2017 | 296 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 992 | 0.030 |
Why?
|
| Ligands | 1 | 2018 | 478 | 0.030 |
Why?
|
| Age of Onset | 1 | 2018 | 344 | 0.030 |
Why?
|
| Vitamin D Deficiency | 1 | 2017 | 107 | 0.030 |
Why?
|
| Models, Animal | 1 | 2017 | 287 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2018 | 237 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2017 | 282 | 0.030 |
Why?
|
| Telomerase | 1 | 2016 | 68 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2009 | 9092 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 259 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2015 | 28 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 189 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 780 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 58 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2015 | 76 | 0.030 |
Why?
|
| Prostate | 1 | 2018 | 422 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 820 | 0.030 |
Why?
|
| Cytokines | 1 | 2018 | 873 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2018 | 711 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 568 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 1567 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2017 | 400 | 0.030 |
Why?
|
| Pedigree | 2 | 2006 | 983 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2017 | 537 | 0.030 |
Why?
|
| Perception | 1 | 2014 | 185 | 0.030 |
Why?
|
| Global Health | 1 | 2015 | 213 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2016 | 936 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2017 | 440 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 457 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1760 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 2785 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1351 | 0.020 |
Why?
|
| Informed Consent | 1 | 2014 | 281 | 0.020 |
Why?
|
| Fertilizers | 1 | 2010 | 9 | 0.020 |
Why?
|
| Sunlight | 1 | 2010 | 28 | 0.020 |
Why?
|
| Skin | 1 | 2014 | 605 | 0.020 |
Why?
|
| Pesticides | 1 | 2010 | 30 | 0.020 |
Why?
|
| Models, Biological | 1 | 2017 | 1814 | 0.020 |
Why?
|
| Protective Agents | 1 | 2010 | 34 | 0.020 |
Why?
|
| Registries | 1 | 2015 | 986 | 0.020 |
Why?
|
| Water | 1 | 2011 | 307 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 985 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2006 | 85 | 0.020 |
Why?
|
| Stroke | 1 | 2015 | 1086 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 189 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2005 | 233 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 548 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 396 | 0.010 |
Why?
|
| Haplotypes | 1 | 2005 | 650 | 0.010 |
Why?
|
| Vancomycin Resistance | 1 | 2001 | 18 | 0.010 |
Why?
|
| Methicillin Resistance | 1 | 2001 | 33 | 0.010 |
Why?
|
| Enterococcus | 1 | 2001 | 35 | 0.010 |
Why?
|
| Neuralgia | 1 | 2001 | 33 | 0.010 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2001 | 51 | 0.010 |
Why?
|
| Herpes Zoster | 1 | 2001 | 80 | 0.010 |
Why?
|
| Community-Acquired Infections | 1 | 2001 | 66 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2001 | 286 | 0.010 |
Why?
|